![Marlies Janßen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Marlies Janßen is currently the Co-Managing Director at Fortuna Herstellung GmbH.
She also holds positions as a Member-Supervisory Board at NSI NV and Erasmus Q-Intelligence BV.
Previously, Ms. Janßen served as the Managing Director at cas central compounding Baden-Württemberg GmbH.
Actieve functies van Marlies Janßen
| Bedrijven | Functie | Begin |
|---|---|---|
| NSI N.V. | Directeur/Bestuurslid | 28-02-2024 |
Fortuna Herstellung GmbH
 Fortuna Herstellung GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | - |
Erasmus Q-Intelligence BV | Directeur/Bestuurslid | - |
Eerdere bekende functies van Marlies Janßen
| Bedrijven | Functie | Einde |
|---|---|---|
cas central compounding Baden-Württemberg GmbH
 cas central compounding Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
NSI NV
 NSI NV Real Estate Investment TrustsFinance Operates as a commercial real estate investment company with a focus on office buildings | Finance |
Fortuna Herstellung GmbH
Fortuna Herstellung GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
cas central compounding Baden-Württemberg GmbH
cas central compounding Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services | Health Technology |
Erasmus Q-Intelligence BV |
